Nkqubela Clinical Team

07/09/2022

👏👏

Original Article from The New England Journal of Medicine — Bedaquiline–Pretomanid–Linezolid Regimens for Drug-Resistant Tuberculosis

26/07/2022

26/05/2022

WHO guidance recommends vastly shorter, improved and better-tolerated treatment for multi drug-resistant TB

05/05/2022

Patients in the bedaquiline group experienced significantly higher rates of treatment success at 24 months. This finding supports the use of short bedaquiline-containing regimens in eligible patients.

04/11/2021

[node:field_description]

02/11/2021

Upending centuries of medical dogma, University of Cape Town researchers found that breathing may be a bigger contributor to the spread of tuberculosis than the signature symptom, coughing, reports writes The New York Times. As much as 90% of TB bacteria released from an infected person may be carri...

26/10/2021

SA is leading the way with DR-TB - Bedaquiline and Delaminid have changed the game for DR-TB patients. Dr Francesca Conradie
at the

19/08/2021

Vaccination opens for 18-34 year old cohort from Friday, 20 August 2021

REGISTRATION LINK: https://sacoronavirus.co.za/evds/

17/04/2021

A new, less toxic, short-course tuberculosis preventive therapy called 3HP is being launched in six districts in South Africa It’s hoped that the course will help address the prevalence of TB in South Africa, which has some of the highest rates in the world. Tiyese Jeranji reports.

01/04/2021

Over a million additional cases of tuberculosis (TB) went undiagnosed and untreated in the last year due to the impact of COVID-19-related lockdowns.

11/03/2021

Over 150,000 people who had TB in South Africa in 2018 were not diagnosed, according to findings from South Africa’s long-awaited National Tuberculosis Prevalence Survey. One reason for this is that an unexpectedly high number of people do not show the typical TB symptoms and are never X-rayed.

28/02/2021

An article by TB proof.

Tuberculosis survivors need comprehensive care to increase their quality of life beyond the completion of tuberculosis treatment. Socioeconomic and medical challenges are faced by many patients after being cured from tuberculosis.1 A systematic review and meta-analysis by Kamila Romanowski and colle...